Concepts (265)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Bronchiolitis | 9 | 2019 | 297 | 3.73 | Why? |
| Bronchiolitis, Viral | 5 | 2019 | 71 | 2.59 | Why? |
| Respiratory Syncytial Virus Infections | 11 | 2021 | 1234 | 2.34 | Why? |
| Respiratory Syncytial Virus, Human | 7 | 2021 | 846 | 1.59 | Why? |
| Respiratory Sounds | 4 | 2019 | 294 | 1.42 | Why? |
| Bronchial Diseases | 2 | 2018 | 31 | 1.39 | Why? |
| Parvoviridae Infections | 3 | 2019 | 222 | 1.32 | Why? |
| Picornaviridae Infections | 7 | 2019 | 544 | 1.27 | Why? |
| Bronchoscopy | 7 | 2021 | 991 | 1.16 | Why? |
| Stents | 4 | 2021 | 916 | 1.03 | Why? |
| Rhinovirus | 8 | 2019 | 979 | 1.02 | Why? |
| Human bocavirus | 3 | 2019 | 142 | 1.01 | Why? |
| Tracheomalacia | 2 | 2019 | 4 | 0.91 | Why? |
| Whooping Cough | 3 | 2018 | 201 | 0.88 | Why? |
| Bronchi | 3 | 2018 | 1048 | 0.86 | Why? |
| Bronchodilator Agents | 2 | 2019 | 444 | 0.84 | Why? |
| Tachypnea | 1 | 2020 | 197 | 0.78 | Why? |
| Vaccines, Acellular | 1 | 2018 | 12 | 0.76 | Why? |
| Respiratory Syncytial Viruses | 4 | 2018 | 612 | 0.75 | Why? |
| Balloon Occlusion | 1 | 2017 | 39 | 0.70 | Why? |
| Th2 Cells | 2 | 2019 | 680 | 0.69 | Why? |
| Infant | 27 | 2021 | 30274 | 0.69 | Why? |
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2017 | 75 | 0.68 | Why? |
| Pertussis Vaccine | 1 | 2018 | 89 | 0.67 | Why? |
| Arteriovenous Malformations | 1 | 2017 | 33 | 0.65 | Why? |
| Community-Acquired Infections | 2 | 2020 | 2328 | 0.65 | Why? |
| Aneurysm | 1 | 2017 | 117 | 0.61 | Why? |
| Pharyngitis | 1 | 2020 | 687 | 0.60 | Why? |
| Foreign Bodies | 2 | 2021 | 171 | 0.60 | Why? |
| Tobacco Smoke Pollution | 1 | 2017 | 181 | 0.56 | Why? |
| Craniocerebral Trauma | 1 | 2017 | 160 | 0.55 | Why? |
| Paramyxoviridae Infections | 2 | 2016 | 364 | 0.51 | Why? |
| Methyl Ethers | 1 | 2012 | 22 | 0.49 | Why? |
| Trachea | 2 | 2017 | 894 | 0.49 | Why? |
| Th1 Cells | 1 | 2018 | 1228 | 0.46 | Why? |
| Weather | 1 | 2017 | 581 | 0.44 | Why? |
| Immunization, Secondary | 1 | 2018 | 1649 | 0.41 | Why? |
| Child | 24 | 2021 | 70012 | 0.40 | Why? |
| Coronary Vessels | 1 | 2017 | 914 | 0.39 | Why? |
| Coinfection | 3 | 2019 | 6820 | 0.37 | Why? |
| Infant, Newborn | 13 | 2020 | 23105 | 0.37 | Why? |
| Air Pollution | 2 | 2017 | 3504 | 0.37 | Why? |
| Air Pollution, Indoor | 1 | 2017 | 816 | 0.36 | Why? |
| Rome | 2 | 2020 | 497 | 0.36 | Why? |
| Coronavirus | 6 | 2020 | 18339 | 0.35 | Why? |
| Cystic Fibrosis | 4 | 2020 | 1104 | 0.35 | Why? |
| Genotype | 3 | 2019 | 4697 | 0.35 | Why? |
| Vascular Surgical Procedures | 1 | 2017 | 882 | 0.35 | Why? |
| Viruses | 2 | 2017 | 2238 | 0.33 | Why? |
| Cough | 1 | 2020 | 4891 | 0.31 | Why? |
| Hospitalization | 13 | 2019 | 54280 | 0.31 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2017 | 1645 | 0.28 | Why? |
| Environmental Monitoring | 1 | 2017 | 3143 | 0.28 | Why? |
| Child, Preschool | 15 | 2021 | 36283 | 0.27 | Why? |
| Seasons | 4 | 2021 | 4071 | 0.26 | Why? |
| Pulmonary Medicine | 2 | 2021 | 706 | 0.26 | Why? |
| Italy | 12 | 2020 | 38444 | 0.25 | Why? |
| Fever | 1 | 2020 | 7795 | 0.25 | Why? |
| Air Pollutants | 2 | 2017 | 3110 | 0.25 | Why? |
| Practice Guidelines as Topic | 5 | 2020 | 15421 | 0.24 | Why? |
| Respiratory Tract Infections | 3 | 2019 | 6817 | 0.24 | Why? |
| Emergency Service, Hospital | 4 | 2020 | 14232 | 0.24 | Why? |
| Decision Making | 1 | 2017 | 3132 | 0.23 | Why? |
| Bronchoscopes | 2 | 2021 | 168 | 0.23 | Why? |
| Acute Disease | 6 | 2019 | 6029 | 0.23 | Why? |
| Virus Diseases | 2 | 2017 | 3779 | 0.23 | Why? |
| Triage | 1 | 2020 | 7151 | 0.22 | Why? |
| Bronchomalacia | 1 | 2019 | 1 | 0.21 | Why? |
| Humans | 52 | 2021 | 930598 | 0.21 | Why? |
| Cathepsins | 1 | 2020 | 204 | 0.20 | Why? |
| Bordetella pertussis | 2 | 2017 | 117 | 0.20 | Why? |
| Epidemics | 2 | 2018 | 6407 | 0.19 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.19 | Why? |
| Th1-Th2 Balance | 1 | 2018 | 19 | 0.19 | Why? |
| Enzyme Activation | 1 | 2020 | 425 | 0.19 | Why? |
| Gastric Dilatation | 1 | 2018 | 1 | 0.19 | Why? |
| Decompression | 1 | 2018 | 1 | 0.19 | Why? |
| Pneumonia | 2 | 2018 | 5652 | 0.19 | Why? |
| Severity of Illness Index | 11 | 2020 | 48226 | 0.19 | Why? |
| Eosinophilia | 2 | 2019 | 292 | 0.18 | Why? |
| Esophageal Atresia | 1 | 2018 | 24 | 0.18 | Why? |
| Tracheoesophageal Fistula | 1 | 2018 | 32 | 0.18 | Why? |
| Interferons | 4 | 2021 | 2885 | 0.18 | Why? |
| Receptors, Cytokine | 1 | 2018 | 75 | 0.18 | Why? |
| Osteochondrodysplasias | 1 | 2017 | 7 | 0.18 | Why? |
| Tannins | 1 | 2017 | 44 | 0.17 | Why? |
| Staining and Labeling | 1 | 2018 | 169 | 0.17 | Why? |
| Antimicrobial Cationic Peptides | 1 | 2019 | 159 | 0.17 | Why? |
| Gelatin | 1 | 2017 | 39 | 0.17 | Why? |
| Work of Breathing | 1 | 2018 | 86 | 0.17 | Why? |
| Saline Solution, Hypertonic | 1 | 2017 | 81 | 0.16 | Why? |
| Diplopia | 1 | 2017 | 84 | 0.16 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.16 | Why? |
| Hospitals, University | 2 | 2019 | 4173 | 0.16 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.16 | Why? |
| Diarrhea | 2 | 2020 | 2743 | 0.16 | Why? |
| Immunity, Maternally-Acquired | 1 | 2018 | 179 | 0.16 | Why? |
| Male | 25 | 2020 | 367725 | 0.16 | Why? |
| Bronchitis | 1 | 2017 | 146 | 0.15 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.15 | Why? |
| Female | 23 | 2020 | 380317 | 0.15 | Why? |
| Societies, Medical | 4 | 2020 | 6907 | 0.15 | Why? |
| Catheterization | 1 | 2018 | 264 | 0.15 | Why? |
| Metapneumovirus | 2 | 2016 | 465 | 0.14 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.14 | Why? |
| Prospective Studies | 6 | 2019 | 43301 | 0.14 | Why? |
| Leukocyte L1 Antigen Complex | 1 | 2016 | 238 | 0.14 | Why? |
| Breath Tests | 1 | 2018 | 338 | 0.14 | Why? |
| Exhalation | 1 | 2018 | 441 | 0.14 | Why? |
| Airway Obstruction | 2 | 2017 | 182 | 0.13 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.13 | Why? |
| Reoperation | 1 | 2017 | 544 | 0.13 | Why? |
| Bronchoalveolar Lavage Fluid | 3 | 2017 | 2309 | 0.13 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.13 | Why? |
| Demography | 1 | 2020 | 1660 | 0.12 | Why? |
| Phenotype | 3 | 2019 | 4037 | 0.12 | Why? |
| Acidosis, Respiratory | 1 | 2012 | 15 | 0.12 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.12 | Why? |
| Intensive Care Units, Pediatric | 1 | 2019 | 1098 | 0.12 | Why? |
| Vaccination | 1 | 2018 | 19050 | 0.12 | Why? |
| Cannula | 1 | 2018 | 750 | 0.12 | Why? |
| Sex Distribution | 1 | 2019 | 2083 | 0.12 | Why? |
| Fluid Therapy | 1 | 2017 | 628 | 0.12 | Why? |
| Gastroenteritis | 1 | 2017 | 489 | 0.12 | Why? |
| Incidence | 3 | 2019 | 25622 | 0.11 | Why? |
| Nose | 1 | 2018 | 1093 | 0.11 | Why? |
| Respiratory Function Tests | 4 | 2020 | 1755 | 0.11 | Why? |
| Retrospective Studies | 6 | 2020 | 105322 | 0.11 | Why? |
| Dermatitis, Atopic | 1 | 2019 | 714 | 0.11 | Why? |
| Radiography | 1 | 2018 | 1576 | 0.11 | Why? |
| Advisory Committees | 1 | 2017 | 1418 | 0.10 | Why? |
| Gene Expression | 1 | 2021 | 3332 | 0.10 | Why? |
| Administration, Inhalation | 2 | 2017 | 1647 | 0.10 | Why? |
| Sequence Analysis, DNA | 1 | 2019 | 2830 | 0.10 | Why? |
| Age Distribution | 1 | 2019 | 3567 | 0.10 | Why? |
| Immune Evasion | 1 | 2020 | 2081 | 0.10 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.10 | Why? |
| Macrophages, Alveolar | 1 | 1993 | 668 | 0.10 | Why? |
| Fatigue | 1 | 2020 | 2479 | 0.09 | Why? |
| Nasal Cavity | 2 | 2017 | 909 | 0.09 | Why? |
| Microbiota | 1 | 2019 | 1240 | 0.09 | Why? |
| Vaccination Coverage | 1 | 2018 | 1249 | 0.09 | Why? |
| Epithelial Cells | 1 | 2021 | 3508 | 0.09 | Why? |
| Antioxidants | 1 | 2018 | 1593 | 0.09 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.09 | Why? |
| Adolescent | 6 | 2020 | 86841 | 0.08 | Why? |
| Anti-Bacterial Agents | 3 | 2018 | 10083 | 0.08 | Why? |
| Protein Domains | 1 | 2020 | 6563 | 0.08 | Why? |
| Europe | 3 | 2019 | 12702 | 0.08 | Why? |
| Patient Care | 1 | 2018 | 1664 | 0.08 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.08 | Why? |
| Oxidative Stress | 1 | 2018 | 2050 | 0.08 | Why? |
| Pregnancy | 2 | 2020 | 23879 | 0.08 | Why? |
| Environmental Exposure | 1 | 2017 | 1558 | 0.08 | Why? |
| Interleukins | 1 | 2012 | 762 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.08 | Why? |
| Length of Stay | 2 | 2017 | 11042 | 0.08 | Why? |
| Guideline Adherence | 1 | 2019 | 2309 | 0.08 | Why? |
| Fetal Blood | 1 | 1989 | 573 | 0.07 | Why? |
| DNA Viruses | 1 | 2007 | 184 | 0.07 | Why? |
| Cities | 1 | 2017 | 4937 | 0.07 | Why? |
| Immunity, Cellular | 1 | 2018 | 3614 | 0.07 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 13720 | 0.07 | Why? |
| Aerosols | 1 | 2021 | 5393 | 0.07 | Why? |
| Databases, Factual | 1 | 2019 | 6248 | 0.07 | Why? |
| Serine Endopeptidases | 1 | 2020 | 4606 | 0.07 | Why? |
| Pulmonary Alveoli | 1 | 1989 | 867 | 0.07 | Why? |
| Oxygen Inhalation Therapy | 1 | 2018 | 3629 | 0.07 | Why? |
| Nasopharynx | 3 | 2018 | 10224 | 0.07 | Why? |
| Oxygen | 1 | 2017 | 3715 | 0.07 | Why? |
| Family | 1 | 2018 | 2909 | 0.07 | Why? |
| Bacterial Infections | 1 | 2017 | 2229 | 0.06 | Why? |
| Protein Binding | 1 | 2020 | 11430 | 0.06 | Why? |
| Case-Control Studies | 2 | 2019 | 17671 | 0.06 | Why? |
| Echocardiography | 1 | 2017 | 3661 | 0.06 | Why? |
| Ultrasonography | 1 | 2018 | 4409 | 0.06 | Why? |
| Virus Replication | 3 | 2020 | 14331 | 0.06 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.06 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.06 | Why? |
| Treatment Outcome | 4 | 2018 | 51732 | 0.06 | Why? |
| Tuberculosis | 1 | 2018 | 2895 | 0.06 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.05 | Why? |
| T-Lymphocytes | 1 | 2018 | 6670 | 0.05 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.05 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.05 | Why? |
| Tomography, X-Ray Computed | 2 | 2018 | 25144 | 0.05 | Why? |
| Viral Load | 2 | 2019 | 15850 | 0.05 | Why? |
| Surveys and Questionnaires | 2 | 2017 | 43792 | 0.05 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.05 | Why? |
| Ubiquitins | 1 | 2021 | 202 | 0.05 | Why? |
| RNA Viruses | 1 | 2007 | 824 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Intubation | 1 | 2021 | 437 | 0.05 | Why? |
| Risk Factors | 2 | 2019 | 71621 | 0.05 | Why? |
| Prognosis | 2 | 2019 | 32490 | 0.05 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2012 | 3607 | 0.05 | Why? |
| Receptors, Interferon | 1 | 2018 | 64 | 0.05 | Why? |
| Dinoprost | 1 | 2018 | 49 | 0.04 | Why? |
| Parainfluenza Virus 2, Human | 1 | 2017 | 52 | 0.04 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.04 | Why? |
| Silicones | 1 | 2017 | 26 | 0.04 | Why? |
| Parainfluenza Virus 1, Human | 1 | 2017 | 71 | 0.04 | Why? |
| Inhalation | 1 | 2018 | 86 | 0.04 | Why? |
| Biomarkers | 2 | 2018 | 23361 | 0.04 | Why? |
| Macrophages | 1 | 1989 | 2784 | 0.04 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.04 | Why? |
| Respiratory Distress Syndrome, Newborn | 1 | 2018 | 124 | 0.04 | Why? |
| Albuterol | 1 | 2017 | 105 | 0.04 | Why? |
| Interleukin-4 | 1 | 2018 | 367 | 0.04 | Why? |
| Monocytes | 1 | 1989 | 2978 | 0.04 | Why? |
| DNA, Viral | 1 | 2007 | 2521 | 0.04 | Why? |
| Adult | 6 | 2021 | 244371 | 0.04 | Why? |
| Multidetector Computed Tomography | 1 | 2019 | 307 | 0.04 | Why? |
| Multilocus Sequence Typing | 1 | 2017 | 264 | 0.04 | Why? |
| Glutathione | 1 | 2018 | 280 | 0.04 | Why? |
| Lung | 3 | 2021 | 31049 | 0.04 | Why? |
| Tidal Volume | 1 | 2018 | 565 | 0.04 | Why? |
| A549 Cells | 1 | 2021 | 2066 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.03 | Why? |
| Virulence Factors | 1 | 2017 | 338 | 0.03 | Why? |
| European Union | 1 | 2018 | 565 | 0.03 | Why? |
| Cross-Over Studies | 1 | 2017 | 867 | 0.03 | Why? |
| Critical Care | 1 | 2017 | 14081 | 0.03 | Why? |
| Macrolides | 1 | 2017 | 369 | 0.03 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.03 | Why? |
| Single-Blind Method | 1 | 2017 | 1283 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| DNA, Bacterial | 1 | 2017 | 835 | 0.03 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.03 | Why? |
| Anti-Asthmatic Agents | 1 | 2017 | 427 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2021 | 3608 | 0.03 | Why? |
| Influenza, Human | 1 | 2016 | 10779 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Physical Therapy Modalities | 1 | 2019 | 1090 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Asthma | 2 | 2021 | 4383 | 0.03 | Why? |
| Neuroimaging | 1 | 2017 | 1106 | 0.02 | Why? |
| Flow Cytometry | 1 | 2018 | 2393 | 0.02 | Why? |
| Dinoprostone | 1 | 1989 | 101 | 0.02 | Why? |
| Interferon-gamma | 1 | 2018 | 2711 | 0.02 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2017 | 11367 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Respiration, Artificial | 1 | 2012 | 22116 | 0.02 | Why? |
| Fluorescent Antibody Technique | 1 | 1989 | 835 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| In Vitro Techniques | 1 | 1989 | 1027 | 0.02 | Why? |
| RNA, Viral | 2 | 2017 | 32276 | 0.02 | Why? |
| Lipopolysaccharides | 1 | 1989 | 848 | 0.02 | Why? |
| Australia | 1 | 2017 | 6306 | 0.02 | Why? |
| RNA, Messenger | 1 | 2018 | 5131 | 0.02 | Why? |
| Species Specificity | 1 | 2007 | 1356 | 0.02 | Why? |
| Feces | 1 | 2016 | 4235 | 0.02 | Why? |
| Magnetic Resonance Imaging | 1 | 2019 | 6551 | 0.02 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.01 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 1989 | 2483 | 0.01 | Why? |
| Disease Progression | 1 | 2016 | 13580 | 0.01 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.01 | Why? |
| Young Adult | 2 | 2018 | 93724 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Public Health | 1 | 2018 | 16359 | 0.01 | Why? |
| Middle Aged | 2 | 2021 | 270681 | 0.01 | Why? |